학술논문
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial
Document Type
Article
Author
Source
In Lung Cancer April 2023 178:96-102
Subject
Language
ISSN
0169-5002